Basic Information | Post buying leads | Suppliers |
Name |
Craviten |
EINECS | N/A |
CAS No. | 55769-64-7 | Density | g/cm3 |
PSA | 114.46000 | LogP | 5.77680 |
Solubility | N/A | Melting Point |
81-83° (Krowczynski) |
Formula | C32H48 N2 O10 . 2 Cl H | Boiling Point | 628.1°Cat760mmHg |
Molecular Weight | 693.74 | Flash Point | 333.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. When heated to decomposition it emits toxic fumes of NOx and HCl. See also ESTERS. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Benzoicacid, 3,4,5-trimethoxy-,1,2-ethanediylbis[(methylimino)(2-ethyl-2,1-ethanediyl)] ester,dihydrochloride, [S-(R*,R*)]-; Butobendin hydrochloride; Butobendinedihydrochloride; Butobendine hydrochloride; Craviten; M 71; M 71(pharmaceutical) |
Molecule structure of Craviten (CAS NO.55769-64-7) :
IUPAC Name: methyl-[2-[methyl-[(2S)-1-(3,4,5-trimethoxybenzoyl)oxybutan-2-yl]azaniumyl]ethyl]-[(2S)-1-(3,4,
5-trimethoxybenzoyl)oxybutan-2-yl]azanium dichloride
Molecular Weight: 693.6528 g/mol
Molecular Formula: C32H50Cl2N2O10
Boiling Point: 628.1 °C at 760 mmHg
Flash Point: 333.7 °C
Enthalpy of Vaporization: 92.94 kJ/mol
Vapour Pressure: 1.09E-15 mmHg at 25 °C
H-Bond Donor: 2
H-Bond Acceptor: 12
Rotatable Bond Count: 21
Exact Mass: 692.284251
MonoIsotopic Mass: 692.284251
Topological Polar Surface Area: 117
Heavy Atom Count: 46
Complexity: 741
Defined Atom StereoCenter Count: 2
Canonical SMILES: CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)[NH+](C)CC[NH+](C)C(CC)COC(=O)C2=CC(=C(C(=C2)OC)OC)OC.[Cl-].[Cl-]
Isomeric SMILES: CC[C@@H](COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)[NH+](C)CC[NH+](C)[C@@H](CC)COC(=O)C2=CC(=C(C(=C2)OC)OC)OC.[Cl-].[Cl-]
InChI: InChI=1S/C32H48N2O10.2ClH/c1-11-23(19-43-31(35)21-15-25(37-5)29(41-9)26(16-21)38-6)33(3)13-14-34(4)24(12-2)20-44-32(36)22-17-27(39-7)30(42-10)28(18-22)40-8;;/h15-18,23-24H,11-14,19-20H2,1-10H3;2*1H/t23-,
24-;;/m0../s1
InChIKey of Craviten (CAS NO.55769-64-7) : NNSPSTCLUNWYSE-WLKYSPGFSA-N
1. | orl-rat LD50:1500 mg/kg | DRFUD4 Drugs of the Future. 5 (1980),610. | ||
2. | ipr-rat LD50:142 mg/kg | PJPPAA Polish Journal of Pharmacology and Pharmacy. 32 (1980),823. | ||
3. | ivn-rat LD50:15,800 µg/kg | MEIEDD Merck Index. 10 (1983),212. | ||
4. | orl-mus LD50:4500 mg/kg | DRFUD4 Drugs of the Future. 5 (1980),610. | ||
5. | ipr-mus LD50:550 mg/kg | PJPPAA Polish Journal of Pharmacology and Pharmacy. 32 (1980),823. | ||
6. | ivn-mus LD50:18 mg/kg | DRFUD4 Drugs of the Future. 5 (1980),610. | ||
7. | ivn-rbt LD50:5100 µg/kg | PJPPAA Polish Journal of Pharmacology and Pharmacy. 32 (1980),823. |
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. An experimental teratogen. When heated to decomposition it emits toxic fumes of NOx and HCl. See also ESTERS.
Craviten (CAS NO.55769-64-7) is also called Butobendine HCl ; Butobendine dihydrochloride ; M 71 ; M-71 ; Benzoic acid, 3,4,5-trimethoxy-, 1,2-ethanediylbis(methylimino)(2-ethyl-2,1-ethanediyl) ester, dihydrochloride, (S-(R*,R*))- .